Annual Lung SPORE Workshop (Abstract Submission)

76 submissions
Created First Name Last Name Email Phone Select a Session Topic Abstract Title First Author First Name First Author Last Name Affiliation List of Additional Authors Your Abstract Submission Upload Abstract Special Characters Included? Abstract Review Status Upload Poster Poster Uploaded Operations
Mon, 03/11/2024 - 14:03 S. Lani Park lpark@cc.hawaii.edu Session 2: Health Disparities in Lung Cancer Racial and ethnic differences in the tumor immune microenvironment of lung adenocarcinomas Lenora Loo University of Hawaii Cancer Center
  • First Name: Alexandra
    Last Name: Binder
    Affiliation: University of Hawaii Cancer Center
  • First Name: Brenda
    Last Name: Hernandez
    Affiliation: University of Hawaii Cancer Center
  • First Name: Owen
    Last Name: Chan
    Affiliation: University of Hawaii Cancer Center
  • First Name: Lynne
    Last Name: Wilkens
    Affiliation: University of Hawaii Cancer Center
  • First Name: Kim
    Last Name: Siegmund
    Affiliation: Keck School of Medicine, University of Southern California
  • First Name: David
    Last Name: Conti
    Affiliation: Keck School of Medicine, University of Southern California
  • First Name: Loïc
    Last Name: Le Marchand
    Affiliation: University of Hawaii Cancer Center
  • First Name: S. Lani
    Last Name: Park
    Affiliation: University of Hawaii Cancer Center
Abstract_Submission.pdf Yes Approved to be a Speaker
Mon, 03/11/2024 - 13:59 Mustafa Al-Dulaimi mustafa_al-dulaimi@dfci.harvard.edu 12087180181 Session 6: Cancer Biology CDK8/19 Co-inhibition Enhances Osimertinib Efficacy in EGFR Mutant Non-Small Cell Lung Cancers (NSCLC) Mustafa Al-Dulaimi DFCI
  • First Name: Antja-Voy
    Last Name: Hartley
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Matthew
    Last Name: Booker
    Affiliation: DFCI
  • First Name: Nathanael
    Last Name: Gray
    Affiliation: Stanford Cancer Institute
  • First Name: Michael
    Last Name: Tolsturokov
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Janne
    Affiliation: DFCI
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:57 Nicole Novaresi nicole.novaresi@utsw.edu Session 6: Cancer Biology Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance response to MAPK pathway-targeted therapies in non-small cell lung cancer Nicole Novaresi Department of Molecular Biology, UTSW
  • First Name: Poorva
    Last Name: Ghosh
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Hui
    Last Name: Deng
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Xuejun
    Last Name: Fan
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Zhiqiang
    Last Name: Ku
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Wei
    Last Name: Xiong
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Xiaorong
    Last Name: Zhou
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Jingfei
    Last Name: Zhu
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Huiyu
    Last Name: Li
    Affiliation: Hamon Center for Therapeutic Oncology Research, UTSW
  • First Name: Mahesh S.
    Last Name: Padanad
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Bethany
    Last Name: Smith
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Chul
    Last Name: Ahn
    Affiliation: School of Public Health, UTSW
  • First Name: John D.
    Last Name: Minna
    Affiliation: Hamon Center for Therapeutic Oncology Research, School of Public Health, Department of Pharmacology, UTSW
  • First Name: Zhiqiang
    Last Name: An
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Ningyan
    Last Name: Zhang
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Kathryn A.
    Last Name: O'Donnell
    Affiliation: Department of Molecular Biology, Harold C. Simmons Comprehensive Cancer Center, Hamon Center for Regenerative Medicine, UTSW
Abstract_Submission.pdf Yes Approved to be a Speaker
Mon, 03/11/2024 - 13:43 Wei Wu vivi2011@uw.edu 2065434940 Session 5: Early Detection and Screening Schema for the plasma/CT matching and detection of lung cancer in a NLST-ACRIN cohort Wei Wu University of Washington School of Medicine
  • First Name: Sudhakar
    Last Name: Pipavath
    Affiliation: UW
  • First Name: Yuzheng
    Last Name: Zhang
    Affiliation: FHCC
  • First Name: Kristin
    Last Name: Lastwika
    Affiliation: FHCC
  • First Name: Timothy W
    Last Name: Randolph
    Affiliation: FHCC
  • First Name: Paul
    Last Name: Lampe
    Affiliation: FHCC
  • First Name: Viswam
    Last Name: Nair
    Affiliation: FHCC
  • First Name: A McGarry
    Last Name: Houghton
    Affiliation: FHCC
  • First Name: Paul
    Last Name: Kinahan
    Affiliation: UW
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:40 Kelly Becht kelly.becht@yale.edu (603) 401-2345 Session 2: Health Disparities in Lung Cancer Disparities in Stereotactic Radiosurgery Receipt in Patients with Brain Metastases from Non-Small Cell Lung Cancer Kelly Becht Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Meghan
    Last Name: Lindsay
    Affiliation: Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine
  • First Name: Pamela
    Last Name: Soulos
    Affiliation: Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine
  • First Name: James
    Last Name: Hansen
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Charu
    Last Name: Singh
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Yi
    Last Name: An
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Sanjay
    Last Name: Aneja
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Department of Medicine, Section of Medical Oncology, Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Department of Neurosurgery, Yale School of Medicine
  • First Name: Henry
    Last Name: Park
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:38 Robert Matera robert.matera@yale.edu Session 4: Small Cell Lung Cancer Longitudinal tumor microenvironment analysis in dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with advanced stage small cell lung cancer Anne Chiang Yale University / Smilow Cancer Center
  • First Name: Robert
    Last Name: Matera
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Kerryan
    Last Name: Ashley
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Barani
    Last Name: Kumar
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Scott
    Last Name: Gettinger
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Roy
    Last Name: Herbst
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Frederick
    Last Name: Wilson
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Kurt
    Last Name: Schalper
    Affiliation: Yale University / Smilow Cancer Center and Yale Department of Pathology
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:33 Darin Dolezal darin.dolezal@yale.edu 203-584-4276 Session 6: Cancer Biology Brain metastasis Fibrosis Predicts Clinical Outcomes and Response to Treatment in Patients with Non-Small Cell Lung Cancer Darin Dolezal Yale School of Medicine - Department of Pathology
  • First Name: Sampada
    Last Name: Chande
    Affiliation: Yale School of Medicine
  • First Name: Anna
    Last Name: Arnal Estapé
    Affiliation: Yale School of Medicine
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale School of Medicine
  • First Name: Declan
    Last Name: McGuone
    Affiliation: Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale School of Medicine
Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:33 Shannon Silva shannon.silva@yale.edu 9784296866 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Unraveling the role of SWI/SNF complexes in acquired resistance to osimertinib in EGFR-mutant lung adenocarcinoma. Shannon Silva Yale University
  • First Name: Fernando
    Last Name: de Miguel
    Affiliation: Yale
  • First Name: Claudia
    Last Name: Gentile
    Affiliation: Dana-Farber/Harvard
  • First Name: William
    Last Name: Feng
    Affiliation: Dana-Farber/Harvard
  • First Name: Akshay
    Last Name: Sankar
    Affiliation: Dana-Farber/Harvard
  • First Name: Francisco
    Last Name: Expósito
    Affiliation: Yale
  • First Name: Wesley
    Last Name: Cai
    Affiliation: Yale
  • First Name: Keita
    Last Name: Maemura
    Affiliation: Yale
  • First Name: Mary Ann
    Last Name: Melnick
    Affiliation: Yale
  • First Name: Camila
    Last Name: Robles-Oteiza
    Affiliation: Yale
  • First Name: Madeline
    Last Name: Hinkley
    Affiliation: Dana-Farber/Harvard
  • First Name: Jeanelle
    Last Name: Tsai
    Affiliation: Dana-Farber/Harvard
  • First Name: Antja-Voy
    Last Name: Hartley
    Affiliation: Dana-Farber/Harvard
  • First Name: Jin
    Last Name: Wei
    Affiliation: Yale
  • First Name: Anna
    Last Name: Wurtz
    Affiliation: Yale
  • First Name: Fangyong
    Last Name: Li
    Affiliation: Yale
  • First Name: Maria
    Last Name: Toki
    Affiliation: Yale
  • First Name: David
    Last Name: Rimm
    Affiliation: Yale
  • First Name: Robert
    Last Name: Homer
    Affiliation: Yale
  • First Name: Craig
    Last Name: Wilen
    Affiliation: Yale
  • First Name: Andrew
    Last Name: Xiao
    Affiliation: Yale
  • First Name: Jun
    Last Name: Qi
    Affiliation: Dana-Farber/Harvard
  • First Name: Qin
    Last Name: Yan
    Affiliation: Yale
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale
  • First Name: Pasi
    Last Name: Jänne
    Affiliation: Dana-Farber/Harvard
  • First Name: Cigall
    Last Name: Kadoch
    Affiliation: Dana-Farber/Harvard
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Yale
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:21 Ramin Salehi-Rad rsalehirad@mednet.ucla.edu 18185715627 Session 3: Immuno-oncology Hyper-Interferon Sensitive influenza induces adaptive immune responses and overcomes resistance to anti-PD-1 in murine NSCLC Ramin Salehi-Rad David Geffen School of Medicine at UCLA
  • First Name: Yushen
    Last Name: Du
    Affiliation: Key Laboratory of Cancer Prevention and Intervention
  • First Name: Tian-Hao
    Last Name: Zhang
    Affiliation: UCLA
  • First Name: Dongdong
    Last Name: Chen
    Affiliation: UCLA
  • First Name: William
    Last Name: Crosson
    Affiliation: UCLA
  • First Name: Abascal
    Last Name: Jensen
    Affiliation: UCLA
  • First Name: Yuan
    Last Name: Shi
    Affiliation: UCLA
  • First Name: Jiang
    Last Name: Hong
    Affiliation: UCLA
  • First Name: Tseng
    Last Name: Yenwen
    Affiliation: UCLA
  • First Name: Liu
    Last Name: Bin
    Affiliation: UCLA
  • First Name: Sun
    Last Name: Ren
    Affiliation: Westlake Laboratory of Life Sciences
  • First Name: Dubinett
    Last Name: Steven
    Affiliation: UCLA
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:21 Hari Shankar Sunil harishankar.sunil@utsouthwestern.edu 9727302166 Session 3: Immuno-oncology, Session 6: Cancer Biology Transmembrane Serine Protease TMPRSS11B promotes tumorigenesis in lung squamous cell carcinoma through enhanced lactate export and modulation of the tumor microenvironment Hari Shankar Sunil UT Southwestern Medical Center
  • First Name: Barrett
    Last Name: Updegraff
    Affiliation: Seagen
  • First Name: Jingfei
    Last Name: Zhu
    Affiliation: UT Southwestern Medical Center
  • First Name: Lisa
    Last Name: Thomas
    Affiliation: UT Southwestern Medical Center
  • First Name: Anthony
    Last Name: Grichuk
    Affiliation: UT Southwestern Medical Center
  • First Name: Bret
    Last Name: Evers
    Affiliation: UT Southwestern Medical Center
  • First Name: Jean
    Last Name: Clemenceau
    Affiliation: Mayo Clinic
  • First Name: Isabel
    Last Name: Barnfather
    Affiliation: Mayo Clinic
  • First Name: John
    Last Name: Minna
    Affiliation: UT Southwestern Medical Center
  • First Name: Ralph
    Last Name: Deberardinis
    Affiliation: UT Southwestern Medical Center
  • First Name: Trudy
    Last Name: Oliver
    Affiliation: Duke University
  • First Name: Tae Hyun
    Last Name: Hwang
    Affiliation: Mayo Clinic
  • First Name: Jinming
    Last Name: Gao
    Affiliation: UT Southwestern Medical Center
  • First Name: Kathryn
    Last Name: O'Donnell
    Affiliation: UT Southwestern Medical Center
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:12 Esra Akbay esra.akbay@utsouthwestern.edu 2146484159 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Kras G12D inhibition causes tumor regression and synergizes with immune checkpoint blockade in immunogenic lung cancer models Esra Akbay UT Southwestern Medical Center Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:09 Arnaud Augert arnaud.augert@yale.edu Session 4: Small Cell Lung Cancer The chromatin remodeling complex PBAF functions as a bona fide tumor suppressor complex in SCLC Arnaud Augert Yale University Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 13:03 Jensen Abascal jensenabascal@g.ucla.edu (310) 266-8937 Session 3: Immuno-oncology In situ vaccination with Flt3l gene modified CD103+ type 1 conventional dendritic cells synergizes with anti-PD-1 checkpoint blockade in murine models of non-small cell lung cancer Jensen Abascal Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA.
  • First Name: Raymond
    Last Name: Lim
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA.
  • First Name: Ramin
    Last Name: Salehi Rad
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. VA Greater Los Angeles Health Care Center, Los Angeles, California
  • First Name: Zhe
    Last Name: Jing
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Michael
    Last Name: Oh
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA;
  • First Name: William
    Last Name: Crosson
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA.
  • First Name: Bitta
    Last Name: Kahangi
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA.
  • First Name: Edgar
    Last Name: Perez Reyes
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA.
  • First Name: Camelia
    Last Name: Dumitras
    Affiliation: Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Diana
    Last Name: Reyimjan
    Affiliation: Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Linh
    Last Name: Tran
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Manash
    Last Name: Paul
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Kostyantyn
    Last Name: Krysan
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Bin
    Last Name: Liu
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Steven
    Last Name: Dubinett
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Pathology and Laboratory Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. VA Greater Los Angeles Health Care Center, Los Angeles, Ca
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 12:48 Yan Yang yyang32@mdanderson.org 7137458407 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Enhanced Sensitivity of EGFR Inhibitor Resistant NSCLC and Drug Tolerant Persister Cells to Chimeric Antigen Receptor (CAR)-NK Cellular Therapy Yan Yang MD Anderson Cancer Center
  • First Name: Monique
    Last Name: Nilsson
    Affiliation: MDACC
  • First Name: Xiaoxing
    Last Name: Yu
    Affiliation: MDACC
  • First Name: Alissa
    Last Name: Poteete
    Affiliation: MDACC
  • First Name: Junqin
    Last Name: He
  • First Name: John
    Last Name: Heymach
Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 12:23 Savannah Kandigian savannah.kandigian@yale.edu Session 6: Cancer Biology Molecular and histological characterization of NSCLC progression to leptomeningeal metastasis with comorbid intraparenchymal disease Savannah Kandigian Department of Pathology, Yale School of Medicine
  • First Name: Sampada
    Last Name: Chande
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Darin
    Last Name: Dolezal
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Tang
    Last Name: Tang
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Anna
    Last Name: Arnal-Estapé
    Affiliation: Department of Medical Oncology, Yale School of Medicine
  • First Name: Sally
    Last Name: Adua
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Stephanie
    Last Name: Cheok
    Affiliation: Department of Neurological Surgery, University of Southern California
  • First Name: Declan
    Last Name: McGuone
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Nicholas
    Last Name: Blondin
    Affiliation: Department of Neurology, Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Department of Neurosurgery, Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Department of Pathology, Yale School of Medicine
Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Mon, 03/11/2024 - 12:15 Elisabeth Martinez elisabeth.martinez@utsouthwestern.edu Session 4: Small Cell Lung Cancer Jumonji Histone Demethylases are Therapeutic Targets in Small Cell Lung Cancer Aiden Nguyen UTSW
  • First Name: Clarissa
    Last Name: Nunez
    Affiliation: UTSW
  • First Name: Tram Anh
    Last Name: Tran
    Affiliation: UTSW
  • First Name: John
    Last Name: Minna
    Affiliation: UTSW
  • First Name: Elisabeth
    Last Name: Martinez
    Affiliation: UTSW
Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 12:01 Mark Lee mark.n.lee@yale.edu 6178200262 Session 3: Immuno-oncology The antigen specificity of tumor-targeting T cells in non-small cell lung cancer Berkay Yahsi Yale Department of Laboratory Medicine
  • First Name: Benjamin
    Last Name: Lu
    Affiliation: Yale Cancer Center
  • First Name: Jianlei
    Last Name: Gu
    Affiliation: Yale School of Public Health
  • First Name: Kalyn
    Last Name: Whitehead
    Affiliation: Yale Department of Laboratory Medicine
  • First Name: Heather
    Last Name: Lazowski
    Affiliation: Yale Cancer Center
  • First Name: Yalai
    Last Name: Bai
    Affiliation: Yale Department of Pathology
  • First Name: David
    Last Name: Rimm
    Affiliation: Yale Department of Pathology
  • First Name: Hongyu
    Last Name: Zhao
    Affiliation: Yale School of Public Health
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Yale Department of Neurosurgery
  • First Name: David
    Last Name: Hafler
    Affiliation: Yale Department of Neurology
  • First Name: Kurt
    Last Name: Schalper
    Affiliation: Yale Department of Pathology
  • First Name: Mark
    Last Name: Lee
    Affiliation: Yale Department of Laboratory Medicine
Abstract_Submission.pdf
Lee_Yale_3.docx43.42 KB
No Approved to be a Poster Presenter
Mon, 03/11/2024 - 11:24 Junghui Koo jkoo22@emory.edu 404-323-3287 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Unlocking Immunochemotherapy Potentials for KRAS and LKB1 Mutant Lung Adenocarcinoma through FAK Inhibition and Immunotherapy with Anti-PD1 Antibody Junghui Koo Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University
  • First Name: Carol
    Last Name: Tucker-Burden
    Affiliation: Emory University
  • First Name: Melissa
    Last Name: Roy
    Affiliation: Emory University
  • First Name: Chunzi
    Last Name: Huang
    Affiliation: Emory University
  • First Name: Wei
    Last Name: Zhou
    Affiliation: Emory University
  • First Name: Melissa
    Last Name: Gilbert-Ross
    Affiliation: Emory University
  • First Name: Haian
    Last Name: Fu
    Affiliation: Emory University
  • First Name: Suresh
    Last Name: Ramalingam
    Affiliation: Emory University
  • First Name: Adam
    Last Name: Marcus
    Affiliation: Emory University
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 11:19 Shayna Thomas-Jardin shayna.thomas-jardin@utsouthwestern.edu 2144630651 Session 3: Immuno-oncology The integrated stress response (ISR) pathway coordinately regulates multiple immune checkpoint proteins in lung cancer Shayna Thomas-Jardin Department of Molecular Biology, UT Southwestern Medical Center
  • First Name: Shruthy
    Last Name: Suresh
    Affiliation: Dept of Mol Biology, UTSW
  • First Name: Nicole
    Last Name: Novaresi
    Affiliation: Dept of Mol Biology, UTSW
  • First Name: Lisa
    Last Name: Thomas
    Affiliation: Dept of Mol Biology, UTSW
  • First Name: Cheryl
    Last Name: Lewis
    Affiliation: Harold C. Simmons Comprehensive Cancer Center, UTSW
  • First Name: Chul
    Last Name: Ahn
    Affiliation: Harold C. Simmons Comprehensive Cancer Center, O’Donnell School of Public Health, UTSW
  • First Name: Bret
    Last Name: Evers
    Affiliation: Department of Pathology, UTSW
  • First Name: Luisa Maris
    Last Name: Solis Soto
    Affiliation: Department of Translational Molecular Pathology, UT MD Anderson Cancer Center
  • First Name: Ignacio
    Last Name: Wistuba
    Affiliation: Department of Translational Molecular Pathology, UT MD Anderson Cancer Center
  • First Name: John
    Last Name: Minna
    Affiliation: Harold C. Simmons Comprehensive Cancer Center, Hamon Center for Therapeutic Oncology Research, Department of Pharmacology, UTSW
  • First Name: Kathryn
    Last Name: O'Donnell
    Affiliation: Dept of Mol Biology, Harold C. Simmons Comprehensive Cancer Center, Hamon Center for Regenerative Science and Medicine, UTSW
Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Mon, 03/11/2024 - 10:46 Don Nguyen don.nguyen@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies The ATM Kinase as a Therapeutic Target in Drug Resistant NSCLC with Brain Metastasis Don Nguyen Yale School of Medicine Abstract_Submission.pdf No Approved to be a Speaker